Effect of carbohydrate moieties on the folate hydrolysis activity of the prostate specific membrane antigen

No abstract is available for this paper.

• Publication year

  2003

• Venue

  The Prostate

• Publication date

  2003-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/pros.10289PMID 12949938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II

  2002cited by this paper
• Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction.

  2000cited by this paper
• N-Linked Oligosaccharides on the Meprin A Metalloprotease Are Important for Secretion and Enzymatic Activity, but Not for Apical Targeting*

  2000cited by this paper
• Prostate‐specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells

  2000cited by this paper
• Prostate-specific membrane antigen is produced in tumor-associated neovasculature.

  1999influential reference
• Site-directed mutagenesis of predicted active site residues in glutamate carboxypeptidase II.

  1999cited by this paper
• Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma

  1998cited by this paper
• Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases.

  1998cited by this paper
• Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line.

  1998cited by this paper
• Structure of membrane glutamate carboxypeptidase.

  1997cited by this paper
• Prostate-specific membrane antigen expression in normal and malignant human tissues.

  1997cited by this paper
• Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.

  1997cited by this paper
• Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.

  1997cited by this paper
• Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy.

  1996cited by this paper
• Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression.

  1995cited by this paper
• Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11.

  1995cited by this paper
• N-glycosylation of human interferon-gamma: glycans at Asn-25 are critical for protease resistance.

  1995cited by this paper
• Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids

  1995cited by this paper
• Report on the American urologic association/American cancer societyscientific seminar on the detection and treatment of early‐stage prostate cancer

  1994cited by this paper
• N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis.

  1993cited by this paper
• Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.

  1993cited by this paper
• Role of oligosaccharides in the processing and function of human transferrin receptors. Effect of the loss of the three N-glycosyl oligosaccharides individually or together.

  1993cited by this paper
• Identification of distinct endoglycosidase (endo) activities in Flavobacterium meningosepticum: endo F1, endo F2, and endo F3. Endo F1 and endo H hydrolyze only high mannose and hybrid glycans.

  1991influential reference
• Glycosylation of the Mr 46,000 mannose 6-phosphate receptor. Effect on ligand binding, stability, and conformation.

  1991cited by this paper
• Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5.

  1990cited by this paper
• Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain.

  1987cited by this paper
• Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.

  1987cited by this paper

• PSMA Theranostics in Prostate Cancer and Beyond: Current and Future Perspectives

  2025cites this paper
• An Overview of Target Membrane Proteins for Near-Infrared Photoimmunotherapy

  2025cites this paper
• PSMA‐Targeting Imprinted Nanogels for Prostate Tumor Localization and Imaging

  2024cites this paper
• Prostate-Specific Membrane Antigen Biology and Pathophysiology in Prostate Carcinoma, an Update: Potential Implications for Targeted Imaging and Therapy

  2024cites this paper
• Prostate‐specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma

  2023cites this paper
• The "Ins and Outs" of Prostate Specific Membrane Antigen (PSMA) as Specific Target in Prostate Cancer Therapy.

  2023cites this paper
• The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activities

  2023cites this paper
• Site-Specific Intact N-Linked Glycopeptide Characterization of Prostate-Specific Membrane Antigen from Metastatic Prostate Cancer Cells

  2022cites this paper
• Potential effective inhibitory compounds against Prostate Specific Membrane Antigen (PSMA): A molecular docking and molecular dynamics study.

  2021cites this paper
• Impact of short‐term Dutasteride treatment on prostate‐specific membrane antigen expression in a mouse xenograft model

  2021cites this paper
• Glycoforms of human prostate‐specific membrane antigen (PSMA) in human cells and prostate tissue

  2021cites this paper
• Nanotheranostics With the Combination of Improved Targeting, Therapeutic Effects, and Molecular Imaging

  2020cites this paper
• GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond.

  2019cites this paper
• Aptamers and apple pies: a mini-review of PSMA aptamers and lessons from Donald S. Coffey.

  2018cites this paper
• A Perspective on the Evolving story of PSMA Biology and PSMA Based Imaging and Endoradiotherapeutic Strategies.

  2018cites this paper
• Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors

  2018cites this paper
• A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies

  2018cites this paper
• Characterization of Glutamate Carboxypeptidase II, its Close Homologs and their Interaction with Ligands

  2015cites this paper
• Prostate-specific membrane antigen as a target for cancer imaging and therapy.

  2015cites this paper
• PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer

  2015cites this paper
• GCPII variants, paralogs and orthologs.

  2012cites this paper
• GCPII imaging and cancer.

  2012cites this paper
• Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer.

  2012cites this paper
• Targeting prostate cancer with synthetic RNA ligands

  2012cites this paper
• Glutamate Carboxypeptidase II : An Overview of Structural Studies and Their Importance for Structure-Based Drug Design and Deciphering the Reaction Mechanism of the Enzyme

  2012cites this paper
• Glutamate carboxypeptidase II: an overview of structural studies and their importance for structure-based drug design and deciphering the reaction mechanism of the enzyme.

  2012cites this paper
• Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells

  2012cites this paper
• Role of TMPRSS2-ERG Gene Fusion in Negative Regulation of PSMA Expression

  2011cites this paper
• In Vitro and In Vivo Responses of Advanced Prostate Tumors to PSMA ADC, an Auristatin-Conjugated Antibody to Prostate-Specific Membrane Antigen

  2011influential citation
• Prostate Specific Membrane Antigen as Biomarker and Therapeutic Target for Prostate Cancer

  2011cites this paper
• Glutamate Carboxypeptidase II

  2011cites this paper
• Tyramide signal amplification for antibody-overlay lectin microarray: a strategy to improve the sensitivity of targeted glycan profiling.

  2011cites this paper
• Prostate‐specific membrane antigen and its truncated form PSM′

  2009cites this paper
• Prostate-SpecificMembraneAntigen and ItsTruncated FormPSM 0

  2009cites this paper
• Clinical trials of cancer therapies targeting prostate-specific membrane antigen.

  2007cites this paper
• Progress in the discovery and development of glutamate carboxypeptidase II inhibitors.

  2007cites this paper
• Expression of glutamate carboxypeptidase II in human brain.

  2007cites this paper
• XPRESSION OF GLUTAMATE CARBOXYPEPTIDASE II IN HUMAN RAIN

  2007cites this paper
• Structure, activity and metabolism of human glutamate carboxypeptidase II

  2007cites this paper
• Apical Transport and Folding of Prostate-specific Membrane Antigen Occurs Independent of Glycan Processing*

  2006cites this paper
• Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer

  2006cites this paper
• Prostate specific membrane antigen (PSMA) expression gives prostate cancer cells a growth advantage in a physiologically relevant folate environment in vitro

  2006cites this paper
• Analysis of Microtubule Mediated Functions of Prostate Specific Membrane Antigen

  2006cites this paper
• Biochemical characterization of human glutamate carboxypeptidase III

  2006cites this paper
• Is prostate-specific membrane antigen a multifunctional protein?

  2005cites this paper
• Semiconductor nanocrystals, nanorods, nanowires and applications in biomolecular integration

  2005cites this paper
• Understanding Prostate-Specific Membrane Antigen and Its Implication in Prostate Cancer

  2005cites this paper
• Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase

  2005cites this paper
• Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness.

  2005cites this paper
• Comparative analysis of prostate‐specific membrane antigen (PSMA) versus a prostate‐specific membrane antigen‐like gene

  2004cites this paper
• Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer

  2004cites this paper
• Identification of the N‐glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity

  2004cites this paper